XOMA Corp (XOMA)
26.44
+0.80
(+3.12%)
USD |
NASDAQ |
Apr 25, 16:00
26.44
0.00 (0.00%)
After-Hours: 17:00
XOMA Revenue (TTM): 4.758M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.758M |
| September 30, 2023 | 4.411M |
| June 30, 2023 | 4.032M |
| March 31, 2023 | 3.357M |
| December 31, 2022 | 6.027M |
| September 30, 2022 | 40.49M |
| June 30, 2022 | 40.98M |
| March 31, 2022 | 40.89M |
| December 31, 2021 | 38.16M |
| September 30, 2021 | 29.80M |
| June 30, 2021 | 29.41M |
| March 31, 2021 | 28.96M |
| December 31, 2020 | 29.39M |
| September 30, 2020 | 2.227M |
| June 30, 2020 | 10.52M |
| March 31, 2020 | 11.04M |
| December 31, 2019 | 18.37M |
| September 30, 2019 | 19.63M |
| June 30, 2019 | 11.67M |
| March 31, 2019 | 12.97M |
| December 31, 2018 | 5.299M |
| September 30, 2018 | 8.971M |
| June 30, 2018 | 44.26M |
| March 31, 2018 | 52.89M |
| December 31, 2017 | 52.69M |
| Date | Value |
|---|---|
| September 30, 2017 | 47.86M |
| June 30, 2017 | 12.31M |
| March 31, 2017 | 1.862M |
| December 31, 2016 | 5.564M |
| September 30, 2016 | 53.22M |
| June 30, 2016 | 54.66M |
| March 31, 2016 | 56.76M |
| December 31, 2015 | 55.45M |
| September 30, 2015 | 11.61M |
| June 30, 2015 | 14.67M |
| March 31, 2015 | 18.11M |
| December 31, 2014 | 18.87M |
| September 30, 2014 | 27.05M |
| June 30, 2014 | 28.23M |
| March 31, 2014 | 29.41M |
| December 31, 2013 | 35.45M |
| September 30, 2013 | 30.31M |
| June 30, 2013 | 31.25M |
| March 31, 2013 | 33.37M |
| December 31, 2012 | 33.78M |
| September 30, 2012 | 36.24M |
| June 30, 2012 | 45.22M |
| March 31, 2012 | 52.47M |
| December 31, 2011 | 58.20M |
| September 30, 2011 | 57.95M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
2.227M
Minimum
Sep 2020
40.98M
Maximum
Jun 2022
19.69M
Average
18.37M
Median
Dec 2019
Revenue (TTM) Benchmarks
| Kinnate Biopharma Inc (DELISTED) | -- |
| Societal CDMO Inc (DELISTED) | 94.64M |
| Corcept Therapeutics Inc | 482.38M |
| Sarepta Therapeutics Inc | 1.243B |
| AbbVie Inc | 54.32B |